CD274 and non-small cell lung carcinoma: In order to analyze a corresponding correlation in patients with metastatic NSCLC and high PD‐L1 expression and thereby improve the therapy situation in this patient group in the future, we investigated the impact of different blood groups on overall survival (OS) and progression‐free survival (PFS) in this distinct cohort.